25 XP   0   0   10

SINOPHARM GROUP CO LTD ADR
Buy, Hold or Sell?

Let's analyse SINOPHARM GROUP CO LTD ADR together

PenkeI guess you are interested in SINOPHARM GROUP CO LTD ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SINOPHARM GROUP CO LTD ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SINOPHARM GROUP CO LTD ADR

I send you an email if I find something interesting about SINOPHARM GROUP CO LTD ADR.

Quick analysis of SINOPHARM GROUP CO LTD ADR (30 sec.)










What can you expect buying and holding a share of SINOPHARM GROUP CO LTD ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
$38.60
Expected worth in 1 year
$95.67
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$57.06
Return On Investment
415.4%

For what price can you sell your share?

Current Price per Share
$13.74
Expected price per share
$12.19 - $14.50
How sure are you?
50%

1. Valuation of SINOPHARM GROUP CO LTD ADR (5 min.)




Live pricePrice per Share (EOD)

$13.74

Intrinsic Value Per Share

$-4.05 - $25.64

Total Value Per Share

$34.56 - $64.25

2. Growth of SINOPHARM GROUP CO LTD ADR (5 min.)




Is SINOPHARM GROUP CO LTD ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$120.3b$15.1b$105.1b87.4%

How much money is SINOPHARM GROUP CO LTD ADR making?

Current yearPrevious yearGrowGrow %
Making money$1.2b$1.1b$72.8m5.8%
Net Profit Margin1.5%1.5%--

How much money comes from the company's main activities?

3. Financial Health of SINOPHARM GROUP CO LTD ADR (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of SINOPHARM GROUP CO LTD ADR? (5 min.)

Welcome investor! SINOPHARM GROUP CO LTD ADR's management wants to use your money to grow the business. In return you get a share of SINOPHARM GROUP CO LTD ADR.

What can you expect buying and holding a share of SINOPHARM GROUP CO LTD ADR?

First you should know what it really means to hold a share of SINOPHARM GROUP CO LTD ADR. And how you can make/lose money.

Speculation

The Price per Share of SINOPHARM GROUP CO LTD ADR is $13.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SINOPHARM GROUP CO LTD ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SINOPHARM GROUP CO LTD ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $38.60. Based on the TTM, the Book Value Change Per Share is $14.27 per quarter. Based on the YOY, the Book Value Change Per Share is $2.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SINOPHARM GROUP CO LTD ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.402.9%0.402.9%1.8913.7%1.3910.2%1.148.3%
Usd Book Value Change Per Share14.27103.8%14.27103.8%2.3016.8%4.7034.2%3.2323.5%
Usd Dividend Per Share0.000.0%0.000.0%0.523.8%0.362.6%0.302.2%
Usd Total Gains Per Share14.27103.8%14.27103.8%2.8220.5%5.0636.8%3.5325.7%
Usd Price Per Share13.05-13.05-12.71-13.41-13.00-
Price to Earnings Ratio32.55-32.55-6.74-13.30-12.02-
Price-to-Total Gains Ratio0.91-0.91-4.51-4.24-7.11-
Price to Book Ratio0.34-0.34-0.52-0.61-0.84-
Price-to-Total Gains Ratio0.91-0.91-4.51-4.24-7.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.738
Number of shares72
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.36
Usd Book Value Change Per Share14.274.70
Usd Total Gains Per Share14.275.06
Gains per Quarter (72 shares)1,027.15364.33
Gains per Year (72 shares)4,108.601,457.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104109409910313541447
208217820820727082904
30123261231731040624361
40164341642641354165818
50205432053551767707275
60246522464462081248732
702876028753723947810189
8032869328628271083211646
9036977369719301218613103
100410864108010331354014560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%16.00.02.088.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%

Fundamentals of SINOPHARM GROUP CO LTD ADR

About SINOPHARM GROUP CO LTD ADR

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-25 03:42:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of SINOPHARM GROUP CO LTD ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit SINOPHARM GROUP CO LTD ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.5% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 1.5%. The company is making a profit. +1
  • The TTM is 1.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY1.5%0.0%
TTM1.5%5Y1.5%0.0%
5Y1.5%10Y1.6%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%2.0%-0.5%
TTM1.5%2.1%-0.6%
YOY1.5%2.5%-1.0%
5Y1.5%2.2%-0.7%
10Y1.6%2.1%-0.5%
1.1.2. Return on Assets

Shows how efficient SINOPHARM GROUP CO LTD ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • 0.3% Return on Assets means that SINOPHARM GROUP CO LTD ADR generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY2.3%-2.0%
TTM0.3%5Y1.9%-1.6%
5Y1.9%10Y2.3%-0.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%0.9%-0.6%
TTM0.3%0.9%-0.6%
YOY2.3%1.2%+1.1%
5Y1.9%1.0%+0.9%
10Y2.3%1.1%+1.2%
1.1.3. Return on Equity

Shows how efficient SINOPHARM GROUP CO LTD ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • 1.7% Return on Equity means SINOPHARM GROUP CO LTD ADR generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 1.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%0.0%
TTM1.7%YOY12.5%-10.8%
TTM1.7%5Y10.5%-8.9%
5Y10.5%10Y11.9%-1.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%2.4%-0.7%
TTM1.7%2.4%-0.7%
YOY12.5%2.4%+10.1%
5Y10.5%2.4%+8.1%
10Y11.9%2.9%+9.0%

1.2. Operating Efficiency of SINOPHARM GROUP CO LTD ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient SINOPHARM GROUP CO LTD ADR is operating .

  • Measures how much profit SINOPHARM GROUP CO LTD ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • An Operating Margin of 3.7% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 3.7%. The company is operating less efficient.
  • The TTM is 3.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY4.5%-0.7%
TTM3.7%5Y4.4%-0.6%
5Y4.4%10Y4.4%+0.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%3.3%+0.4%
TTM3.7%2.6%+1.1%
YOY4.5%3.4%+1.1%
5Y4.4%3.4%+1.0%
10Y4.4%3.1%+1.3%
1.2.2. Operating Ratio

Measures how efficient SINOPHARM GROUP CO LTD ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 0.964. The company is less efficient in keeping operating costs low.
  • The TTM is 0.964. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.964TTM0.9640.000
TTM0.964YOY0.958+0.006
TTM0.9645Y0.959+0.005
5Y0.95910Y0.9590.000
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9641.618-0.654
TTM0.9641.515-0.551
YOY0.9581.422-0.464
5Y0.9591.246-0.287
10Y0.9591.155-0.196

1.3. Liquidity of SINOPHARM GROUP CO LTD ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if SINOPHARM GROUP CO LTD ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.39 means the company has $1.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 1.395. The company is just able to pay all its short-term debts.
  • The TTM is 1.395. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.395TTM1.3950.000
TTM1.395YOY1.359+0.035
TTM1.3955Y1.336+0.058
5Y1.33610Y1.311+0.025
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3951.374+0.021
TTM1.3951.398-0.003
YOY1.3591.424-0.065
5Y1.3361.401-0.065
10Y1.3111.350-0.039
1.3.2. Quick Ratio

Measures if SINOPHARM GROUP CO LTD ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • A Quick Ratio of 1.03 means the company can pay off $1.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 1.034. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.034. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.034TTM1.0340.000
TTM1.034YOY1.094-0.061
TTM1.0345Y1.001+0.033
5Y1.00110Y0.997+0.004
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0340.738+0.296
TTM1.0340.751+0.283
YOY1.0940.807+0.287
5Y1.0010.788+0.213
10Y0.9970.855+0.142

1.4. Solvency of SINOPHARM GROUP CO LTD ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of SINOPHARM GROUP CO LTD ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.69 means that SINOPHARM GROUP CO LTD ADR assets are financed with 68.6% credit (debt) and the remaining percentage (100% - 68.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 0.686. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.686. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.686TTM0.6860.000
TTM0.686YOY0.698-0.012
TTM0.6865Y0.703-0.016
5Y0.70310Y0.706-0.004
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6860.614+0.072
TTM0.6860.608+0.078
YOY0.6980.600+0.098
5Y0.7030.595+0.108
10Y0.7060.594+0.112
1.4.2. Debt to Equity Ratio

Measures if SINOPHARM GROUP CO LTD ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 352.7% means that company has $3.53 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The MRQ is 3.527. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.527. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.527TTM3.5270.000
TTM3.527YOY3.742-0.215
TTM3.5275Y3.815-0.287
5Y3.81510Y3.652+0.163
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5271.558+1.969
TTM3.5271.630+1.897
YOY3.7421.697+2.045
5Y3.8151.704+2.111
10Y3.6521.760+1.892

2. Market Valuation of SINOPHARM GROUP CO LTD ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings SINOPHARM GROUP CO LTD ADR generates.

  • Above 15 is considered overpriced but always compare SINOPHARM GROUP CO LTD ADR to the Medical Distribution industry mean.
  • A PE ratio of 32.55 means the investor is paying $32.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The EOD is 34.271. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.555. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.555. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD34.271MRQ32.555+1.716
MRQ32.555TTM32.5550.000
TTM32.555YOY6.742+25.812
TTM32.5555Y13.300+19.255
5Y13.30010Y12.018+1.282
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD34.27112.498+21.773
MRQ32.55513.542+19.013
TTM32.55515.818+16.737
YOY6.74218.843-12.101
5Y13.30015.030-1.730
10Y12.01821.149-9.131
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The EOD is 21.130. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.072. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.072. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.130MRQ20.072+1.058
MRQ20.072TTM20.0720.000
TTM20.072YOY3.099+16.972
TTM20.0725Y8.260+11.811
5Y8.26010Y-0.587+8.848
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD21.1307.031+14.099
MRQ20.0729.109+10.963
TTM20.07212.435+7.637
YOY3.0990.763+2.336
5Y8.2603.139+5.121
10Y-0.5874.036-4.623
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of SINOPHARM GROUP CO LTD ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.34 means the investor is paying $0.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of SINOPHARM GROUP CO LTD ADR:

  • The EOD is 0.356. Based on the equity, the company is cheap. +2
  • The MRQ is 0.338. Based on the equity, the company is cheap. +2
  • The TTM is 0.338. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.356MRQ0.338+0.018
MRQ0.338TTM0.3380.000
TTM0.338YOY0.522-0.184
TTM0.3385Y0.608-0.270
5Y0.60810Y0.841-0.233
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.3560.995-0.639
MRQ0.3381.119-0.781
TTM0.3381.133-0.795
YOY0.5221.302-0.780
5Y0.6081.297-0.689
10Y0.8412.044-1.203
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SINOPHARM GROUP CO LTD ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.26614.2660%2.303+519%4.701+203%3.228+342%
Book Value Per Share--38.60338.6030%24.337+59%24.375+58%17.517+120%
Current Ratio--1.3951.3950%1.359+3%1.336+4%1.311+6%
Debt To Asset Ratio--0.6860.6860%0.698-2%0.703-2%0.706-3%
Debt To Equity Ratio--3.5273.5270%3.742-6%3.815-8%3.652-3%
Dividend Per Share----0%0.518-100%0.359-100%0.304-100%
Eps--0.4010.4010%1.885-79%1.395-71%1.136-65%
Free Cash Flow Per Share--0.6500.6500%4.101-84%2.381-73%1.718-62%
Free Cash Flow To Equity Per Share--0.3120.3120%2.842-89%0.922-66%1.106-72%
Gross Profit Margin---0.930-0.9300%-0.961+3%-0.971+4%-0.783-16%
Intrinsic Value_10Y_max--25.643--------
Intrinsic Value_10Y_min---4.047--------
Intrinsic Value_1Y_max--2.427--------
Intrinsic Value_1Y_min--1.195--------
Intrinsic Value_3Y_max--7.401--------
Intrinsic Value_3Y_min--2.225--------
Intrinsic Value_5Y_max--12.505--------
Intrinsic Value_5Y_min--1.751--------
Market Cap8574311787.904-374%40674474900.00040674474900.0000%7932707552.000+413%14876134485.472+173%11365099545.072+258%
Net Profit Margin--0.0150.0150%0.015-2%0.0150%0.016-6%
Operating Margin--0.0370.0370%0.045-16%0.044-15%0.044-14%
Operating Ratio--0.9640.9640%0.958+1%0.959+1%0.959+0%
Pb Ratio0.356+5%0.3380.3380%0.522-35%0.608-44%0.841-60%
Pe Ratio34.271+5%32.55532.5550%6.742+383%13.300+145%12.018+171%
Price Per Share13.738+5%13.05013.0500%12.710+3%13.411-3%12.998+0%
Price To Free Cash Flow Ratio21.130+5%20.07220.0720%3.099+548%8.260+143%-0.587+103%
Price To Total Gains Ratio0.963+5%0.9150.9150%4.506-80%4.239-78%7.106-87%
Quick Ratio--1.0341.0340%1.094-6%1.001+3%0.997+4%
Return On Assets--0.0030.0030%0.023-86%0.019-83%0.023-86%
Return On Equity--0.0170.0170%0.125-87%0.105-84%0.119-86%
Total Gains Per Share--14.26614.2660%2.820+406%5.060+182%3.531+304%
Usd Book Value--120318745000.000120318745000.0000%15189548220.000+692%34458179838.800+249%20555209955.200+485%
Usd Book Value Change Per Share--14.26614.2660%2.303+519%4.701+203%3.228+342%
Usd Book Value Per Share--38.60338.6030%24.337+59%24.375+58%17.517+120%
Usd Dividend Per Share----0%0.518-100%0.359-100%0.304-100%
Usd Eps--0.4010.4010%1.885-79%1.395-71%1.136-65%
Usd Free Cash Flow--2026474799.8622026474799.8620%2559383604.000-21%1809976204.772+12%1234226308.186+64%
Usd Free Cash Flow Per Share--0.6500.6500%4.101-84%2.381-73%1.718-62%
Usd Free Cash Flow To Equity Per Share--0.3120.3120%2.842-89%0.922-66%1.106-72%
Usd Market Cap8574311787.904-374%40674474900.00040674474900.0000%7932707552.000+413%14876134485.472+173%11365099545.072+258%
Usd Price Per Share13.738+5%13.05013.0500%12.710+3%13.411-3%12.998+0%
Usd Profit--1249418880.0001249418880.0000%1176540390.000+6%1070269377.600+17%844278825.000+48%
Usd Revenue--82326599970.00082326599970.0000%76196361900.000+8%70420176961.200+17%53244375159.000+55%
Usd Total Gains Per Share--14.26614.2660%2.820+406%5.060+182%3.531+304%
 EOD+2 -6MRQTTM+0 -0YOY+17 -195Y+19 -1710Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of SINOPHARM GROUP CO LTD ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.271
Price to Book Ratio (EOD)Between0-10.356
Net Profit Margin (MRQ)Greater than00.015
Operating Margin (MRQ)Greater than00.037
Quick Ratio (MRQ)Greater than11.034
Current Ratio (MRQ)Greater than11.395
Debt to Asset Ratio (MRQ)Less than10.686
Debt to Equity Ratio (MRQ)Less than13.527
Return on Equity (MRQ)Greater than0.150.017
Return on Assets (MRQ)Greater than0.050.003
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of SINOPHARM GROUP CO LTD ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.222
Ma 20Greater thanMa 5012.900
Ma 50Greater thanMa 10013.323
Ma 100Greater thanMa 20012.976
OpenGreater thanClose13.690
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Stockholders Equity  6,134,168-2,734,1723,399,99503,399,995-353,2573,046,739-3,050,577-3,838



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets383,394,844
Total Liabilities263,076,099
Total Stockholder Equity74,582,217
 As reported
Total Liabilities 263,076,099
Total Stockholder Equity+ 74,582,217
Total Assets = 383,394,844

Assets

Total Assets383,394,844
Total Current Assets336,835,100
Long-term Assets46,559,744
Total Current Assets
Cash And Cash Equivalents 63,808,538
Short-term Investments 547
Net Receivables 185,790,359
Inventory 60,027,648
Other Current Assets 27,208,555
Total Current Assets  (as reported)336,835,100
Total Current Assets  (calculated)336,835,647
+/- 547
Long-term Assets
Property Plant Equipment 19,897,657
Intangible Assets 10,196,149
Long-term Assets Other 5,915,252
Long-term Assets  (as reported)46,559,744
Long-term Assets  (calculated)36,009,058
+/- 10,550,686

Liabilities & Shareholders' Equity

Total Current Liabilities241,490,637
Long-term Liabilities21,585,462
Total Stockholder Equity74,582,217
Total Current Liabilities
Short-term Debt 54,730,449
Accounts payable 146,632,453
Other Current Liabilities 40,127,735
Total Current Liabilities  (as reported)241,490,637
Total Current Liabilities  (calculated)241,490,637
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)21,585,462
Long-term Liabilities  (calculated)0
+/- 21,585,462
Total Stockholder Equity
Common Stock3,120,656
Retained Earnings 49,410,060
Accumulated Other Comprehensive Income 22,055,339
Other Stockholders Equity -3,838
Total Stockholder Equity (as reported)74,582,217
Total Stockholder Equity (calculated)74,582,217
+/-0
Other
Cash and Short Term Investments 63,809,085
Common Stock Shares Outstanding 3,116,818
Liabilities and Stockholders Equity 383,394,844
Net Debt 8,176,789
Short Long Term Debt Total 71,985,327



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
11,590,265
14,287,261
16,114,897
28,275,250
42,014,480
67,627,852
79,847,109
105,453,110
128,655,739
138,267,028
157,711,590
169,539,028
235,771,077
269,888,371
311,236,706
335,412,321
364,775,134
383,394,844
383,394,844364,775,134335,412,321311,236,706269,888,371235,771,077169,539,028157,711,590138,267,028128,655,739105,453,11079,847,10967,627,85242,014,48028,275,25016,114,89714,287,26111,590,265
   > Total Current Assets 
9,397,590
11,955,288
13,681,470
25,287,235
34,863,300
56,233,061
66,016,320
89,713,376
110,272,464
116,752,068
132,759,719
144,843,393
204,654,573
229,999,688
267,609,973
290,922,141
319,406,382
336,835,100
336,835,100319,406,382290,922,141267,609,973229,999,688204,654,573144,843,393132,759,719116,752,068110,272,46489,713,37666,016,32056,233,06134,863,30025,287,23513,681,47011,955,2889,397,590
       Cash And Cash Equivalents 
1,838,797
1,955,596
1,712,119
6,937,243
7,474,698
13,091,012
9,721,992
14,001,962
15,232,356
19,919,154
25,572,759
29,011,436
40,298,985
39,191,967
50,178,265
43,529,428
55,221,624
63,808,538
63,808,53855,221,62443,529,42850,178,26539,191,96740,298,98529,011,43625,572,75919,919,15415,232,35614,001,9629,721,99213,091,0127,474,6986,937,2431,712,1191,955,5961,838,797
       Short-term Investments 
15
15
15
15
990
1,163
1,559
1,122
728
2,069
5,468
175,614
41,199
156
39,141
11,749
498
547
54749811,74939,14115641,199175,6145,4682,0697281,1221,5591,16399015151515
       Net Receivables 
519,232
605,504
616,907
0
19,125,138
29,728,307
41,084,344
55,966,062
70,579,616
73,255,799
75,185,885
84,914,018
110,363,727
126,591,699
146,049,207
172,575,535
201,909,882
185,790,359
185,790,359201,909,882172,575,535146,049,207126,591,699110,363,72784,914,01875,185,88573,255,79970,579,61655,966,06241,084,34429,728,30719,125,1380616,907605,504519,232
       Inventory 
2,043,361
2,634,374
3,154,820
4,272,807
7,530,376
12,214,060
13,618,051
16,702,338
20,308,570
22,348,576
25,759,525
26,768,692
35,388,863
42,594,396
47,085,450
51,499,625
60,925,831
60,027,648
60,027,64860,925,83151,499,62547,085,45042,594,39635,388,86326,768,69225,759,52522,348,57620,308,57016,702,33813,618,05112,214,0607,530,3764,272,8073,154,8202,634,3742,043,361
       Other Current Assets 
4,996,185
6,759,799
8,197,609
0
732,098
1,198,519
1,590,374
3,041,892
4,151,194
1,226,470
6,236,082
13,523,930
16,878,103
19,419,472
21,664,247
20,506,022
1,348,547
27,208,555
27,208,5551,348,54720,506,02221,664,24719,419,47216,878,10313,523,9306,236,0821,226,4704,151,1943,041,8921,590,3741,198,519732,09808,197,6096,759,7994,996,185
   > Long-term Assets 
2,192,675
2,331,973
2,433,427
2,988,015
7,151,180
11,394,791
13,830,789
15,739,734
18,383,275
21,514,960
24,951,871
24,695,635
31,116,504
39,888,683
43,626,733
44,490,180
45,368,752
46,559,744
46,559,74445,368,75244,490,18043,626,73339,888,68331,116,50424,695,63524,951,87121,514,96018,383,27515,739,73413,830,78911,394,7917,151,1802,988,0152,433,4272,331,9732,192,675
       Property Plant Equipment 
1,087,957
1,192,945
1,257,019
1,447,946
3,330,750
4,430,655
6,399,490
7,587,983
8,547,974
9,130,936
8,081,019
9,144,258
12,692,461
16,271,966
17,065,920
17,597,506
17,792,353
19,897,657
19,897,65717,792,35317,597,50617,065,92016,271,96612,692,4619,144,2588,081,0199,130,9368,547,9747,587,9836,399,4904,430,6553,330,7501,447,9461,257,0191,192,9451,087,957
       Goodwill 
0
0
0
0
0
0
3,396,955
3,466,040
3,723,888
3,997,101
3,834,871
4,127,286
4,899,384
5,664,072
7,287,394
7,199,009
7,155,580
0
07,155,5807,199,0097,287,3945,664,0724,899,3844,127,2863,834,8713,997,1013,723,8883,466,0403,396,955000000
       Long Term Investments 
0
0
0
0
0
0
0
1,005,440
10,682
1,455,691
3,792,910
6,283,149
7,065,114
0
0
0
0
0
000007,065,1146,283,1493,792,9101,455,69110,6821,005,4400000000
       Intangible Assets 
613,669
601,784
606,967
895,451
2,257,087
5,574,947
2,152,539
2,137,249
2,624,122
2,722,868
2,447,901
2,546,893
2,598,350
5,133,390
5,271,834
5,002,964
4,870,150
10,196,149
10,196,1494,870,1505,002,9645,271,8345,133,3902,598,3502,546,8932,447,9012,722,8682,624,1222,137,2492,152,5395,574,9472,257,087895,451606,967601,784613,669
       Long-term Assets Other 
90,714
86,413
66,982
170,660
788,261
377,510
590,913
1,080,183
1,519,662
3,563,884
5,745,596
2,512,018
2,830,252
3,511,001
3,954,791
3,731,078
3,730,964
5,915,252
5,915,2523,730,9643,731,0783,954,7913,511,0012,830,2522,512,0185,745,5963,563,8841,519,6621,080,183590,913377,510788,261170,66066,98286,41390,714
> Total Liabilities 
9,000,004
11,668,913
12,704,315
15,770,795
27,295,400
47,239,766
57,103,908
76,841,760
92,366,110
97,611,323
113,179,154
118,269,374
167,495,310
192,949,004
221,289,385
235,758,386
254,705,944
263,076,099
263,076,099254,705,944235,758,386221,289,385192,949,004167,495,310118,269,374113,179,15497,611,32392,366,11076,841,76057,103,90847,239,76627,295,40015,770,79512,704,31511,668,9139,000,004
   > Total Current Liabilities 
8,269,708
10,946,892
11,877,776
14,754,855
25,754,076
40,291,560
50,105,470
70,841,179
86,019,825
94,682,070
99,737,359
110,876,304
160,074,381
178,424,634
203,977,099
219,306,549
234,962,957
241,490,637
241,490,637234,962,957219,306,549203,977,099178,424,634160,074,381110,876,30499,737,35994,682,07086,019,82570,841,17950,105,47040,291,56025,754,07614,754,85511,877,77610,946,8928,269,708
       Short-term Debt 
1,704,351
2,161,596
1,504,170
1,284,313
3,344,182
8,666,785
10,888,203
21,007,276
25,232,854
28,203,994
22,362,578
30,162,908
50,085,218
43,668,919
56,365,093
56,699,696
54,633,193
54,730,449
54,730,44954,633,19356,699,69656,365,09343,668,91950,085,21830,162,90822,362,57828,203,99425,232,85421,007,27610,888,2038,666,7853,344,1821,284,3131,504,1702,161,5961,704,351
       Short Long Term Debt 
0
0
0
0
0
0
0
25,141,343
210,810
28,355,283
22,362,578
30,162,908
50,085,218
42,476,715
54,958,954
55,151,650
52,997,246
0
052,997,24655,151,65054,958,95442,476,71550,085,21830,162,90822,362,57828,355,283210,81025,141,3430000000
       Accounts payable 
5,629,830
7,209,584
9,053,071
12,135,002
19,831,205
27,053,995
35,137,489
45,018,844
55,332,150
60,136,795
68,845,508
69,179,367
87,715,715
108,920,477
116,731,565
132,866,874
144,616,691
146,632,453
146,632,453144,616,691132,866,874116,731,565108,920,47787,715,71569,179,36768,845,50860,136,79555,332,15045,018,84435,137,48927,053,99519,831,20512,135,0029,053,0717,209,5845,629,830
       Other Current Liabilities 
935,527
1,575,712
1,320,535
1,335,540
2,578,689
4,570,780
4,079,778
4,815,059
5,454,821
6,341,281
8,529,273
11,534,029
6,323,223
8,418,976
8,012,457
8,119,576
7,712,374
40,127,735
40,127,7357,712,3748,119,5768,012,4578,418,9766,323,22311,534,0298,529,2736,341,2815,454,8214,815,0594,079,7784,570,7802,578,6891,335,5401,320,5351,575,712935,527
   > Long-term Liabilities 
730,296
722,021
826,539
1,015,940
1,541,324
6,948,206
6,998,438
6,000,581
6,346,285
2,929,253
13,441,795
7,393,070
7,420,929
14,524,370
17,312,286
16,451,837
19,742,987
21,585,462
21,585,46219,742,98716,451,83717,312,28614,524,3707,420,9297,393,07013,441,7952,929,2536,346,2856,000,5816,998,4386,948,2061,541,3241,015,940826,539722,021730,296
       Other Liabilities 
0
0
0
0
0
0
0
1,866,514
17,742
2,321,058
2,306,496
2,568,564
2,401,828
3,054,035
5,150,549
4,783,287
4,785,994
0
04,785,9944,783,2875,150,5493,054,0352,401,8282,568,5642,306,4962,321,05817,7421,866,5140000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
41,310
642
57,528
32,109
46,558
50,047
66,345
81,261
76,608
74,436
0
074,43676,60881,26166,34550,04746,55832,10957,52864241,3100000000
> Total Stockholder Equity
1,759,628
1,683,759
2,264,230
10,910,856
11,711,138
15,673,849
17,078,291
21,815,546
27,381,867
30,051,626
31,810,928
35,257,635
42,821,826
47,422,146
56,358,845
61,886,015
68,068,559
74,582,217
74,582,21768,068,55961,886,01556,358,84547,422,14642,821,82635,257,63531,810,92830,051,62627,381,86721,815,54617,078,29115,673,84911,711,13810,910,8562,264,2301,683,7591,759,628
   Common Stock
0
0
0
2,264,568
2,264,568
2,402,625
2,402,625
2,568,293
2,767,095
2,767,095
2,767,095
2,767,095
2,971,656
2,971,656
3,120,656
3,120,656
3,120,656
3,120,656
3,120,6563,120,6563,120,6563,120,6562,971,6562,971,6562,767,0952,767,0952,767,0952,767,0952,568,2932,402,6252,402,6252,264,5682,264,568000
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,307,593
-4,388,067
-4,390,577
22,055,339
22,055,339-4,390,577-4,388,067-4,307,59300000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
8,646,288
9,446,570
13,271,224
14,675,666
13,935,162
24,614,772
17,249,954
15,606,294
32,490,540
39,850,170
44,450,490
24,637,647
24,637,647
22,077,817
-3,838
-3,83822,077,81724,637,64724,637,64744,450,49039,850,17032,490,54015,606,29417,249,95424,614,77213,935,16214,675,66613,271,2249,446,5708,646,288000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue596,569,565
Cost of Revenue-548,057,887
Gross Profit48,511,67848,511,678
 
Operating Income (+$)
Gross Profit48,511,678
Operating Expense-26,837,263
Operating Income22,318,48721,674,415
 
Operating Expense (+$)
Research Development-
Selling General Administrative8,678,071
Selling And Marketing Expenses17,471,692
Operating Expense26,837,26326,149,763
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,294,981
Other Finance Cost-330,334
Net Interest Income-2,964,647
 
Pretax Income (+$)
Operating Income22,318,487
Net Interest Income-2,964,647
Other Non-Operating Income Expenses-
Income Before Tax (EBT)19,512,13725,124,837
EBIT - interestExpense = 19,023,506
13,556,069
12,348,741
Interest Expense3,294,981
Earnings Before Interest and Taxes (EBIT)22,318,48722,807,118
Earnings Before Interest and Taxes (EBITDA)24,589,863
 
After tax Income (+$)
Income Before Tax19,512,137
Tax Provision-4,400,314
Net Income From Continuing Ops14,600,26515,111,823
Net Income9,053,760
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses574,895,150
Total Other Income/Expenses Net-2,806,3502,964,647
 

Technical Analysis of SINOPHARM GROUP CO LTD ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SINOPHARM GROUP CO LTD ADR. The general trend of SINOPHARM GROUP CO LTD ADR is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SINOPHARM GROUP CO LTD ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SINOPHARM GROUP CO LTD ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 14.16 < 14.45 < 14.50.

The bearish price targets are: 13.64 > 13.20 > 12.19.

Tweet this
SINOPHARM GROUP CO LTD ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SINOPHARM GROUP CO LTD ADR. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SINOPHARM GROUP CO LTD ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SINOPHARM GROUP CO LTD ADR. The current macd is 0.11871562.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the SINOPHARM GROUP CO LTD ADR price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for SINOPHARM GROUP CO LTD ADR. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the SINOPHARM GROUP CO LTD ADR price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SINOPHARM GROUP CO LTD ADR Daily Moving Average Convergence/Divergence (MACD) ChartSINOPHARM GROUP CO LTD ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SINOPHARM GROUP CO LTD ADR. The current adx is 16.28.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy SINOPHARM GROUP CO LTD ADR shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
SINOPHARM GROUP CO LTD ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SINOPHARM GROUP CO LTD ADR. The current sar is 12.40.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
SINOPHARM GROUP CO LTD ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SINOPHARM GROUP CO LTD ADR. The current rsi is 61.22. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
SINOPHARM GROUP CO LTD ADR Daily Relative Strength Index (RSI) ChartSINOPHARM GROUP CO LTD ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SINOPHARM GROUP CO LTD ADR. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SINOPHARM GROUP CO LTD ADR price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
SINOPHARM GROUP CO LTD ADR Daily Stochastic Oscillator ChartSINOPHARM GROUP CO LTD ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SINOPHARM GROUP CO LTD ADR. The current cci is 134.06.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
SINOPHARM GROUP CO LTD ADR Daily Commodity Channel Index (CCI) ChartSINOPHARM GROUP CO LTD ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SINOPHARM GROUP CO LTD ADR. The current cmo is 33.90.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SINOPHARM GROUP CO LTD ADR Daily Chande Momentum Oscillator (CMO) ChartSINOPHARM GROUP CO LTD ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SINOPHARM GROUP CO LTD ADR. The current willr is -8.40236686.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
SINOPHARM GROUP CO LTD ADR Daily Williams %R ChartSINOPHARM GROUP CO LTD ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SINOPHARM GROUP CO LTD ADR.

SINOPHARM GROUP CO LTD ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SINOPHARM GROUP CO LTD ADR. The current atr is 0.27367756.

SINOPHARM GROUP CO LTD ADR Daily Average True Range (ATR) ChartSINOPHARM GROUP CO LTD ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SINOPHARM GROUP CO LTD ADR. The current obv is 890,438.

SINOPHARM GROUP CO LTD ADR Daily On-Balance Volume (OBV) ChartSINOPHARM GROUP CO LTD ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SINOPHARM GROUP CO LTD ADR. The current mfi is 51.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
SINOPHARM GROUP CO LTD ADR Daily Money Flow Index (MFI) ChartSINOPHARM GROUP CO LTD ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SINOPHARM GROUP CO LTD ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

SINOPHARM GROUP CO LTD ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SINOPHARM GROUP CO LTD ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.222
Ma 20Greater thanMa 5012.900
Ma 50Greater thanMa 10013.323
Ma 100Greater thanMa 20012.976
OpenGreater thanClose13.690
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of SINOPHARM GROUP CO LTD ADR with someone you think should read this too:
  • Are you bullish or bearish on SINOPHARM GROUP CO LTD ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SINOPHARM GROUP CO LTD ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SINOPHARM GROUP CO LTD ADR

I send you an email if I find something interesting about SINOPHARM GROUP CO LTD ADR.


Comments

How you think about this?

Leave a comment

Stay informed about SINOPHARM GROUP CO LTD ADR.

Receive notifications about SINOPHARM GROUP CO LTD ADR in your mailbox!